Back to Journals » Patient Related Outcome Measures » Volume 5

Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life

Total article views   HTML views PDF downloads Totals
24,004 Dovepress* 10,555+ 2,168 12,723
PubMed Central* 13,449 1,349 14,798
Totals 24,004 3,517 27,521
*Since 4 April 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar